Compare AMWD & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMWD | PACB |
|---|---|---|
| Founded | 1980 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 566.8M | 462.8M |
| IPO Year | 1995 | 2010 |
| Metric | AMWD | PACB |
|---|---|---|
| Price | $47.55 | $1.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $59.50 | $1.67 |
| AVG Volume (30 Days) | 410.1K | ★ 6.1M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,709,585,000.00 | $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | N/A | $12.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $33.29 | $1.09 |
| 52 Week High | $72.16 | $2.73 |
| Indicator | AMWD | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 69.39 | 43.25 |
| Support Level | $47.15 | $1.18 |
| Resistance Level | $58.38 | $1.40 |
| Average True Range (ATR) | 2.26 | 0.13 |
| MACD | 1.08 | -0.01 |
| Stochastic Oscillator | 98.44 | 22.40 |
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.